HTx proton therapy case study workshop

Brussels, Belgium (hybrid)

We’re excited to announce our upcoming hybrid workshop as part of the  H2020 project-HTx, focusing on integrating scientific findings into HTA practices. The event has been postponed to September 2024. The exact new date will be confirmed soon.

Since 2019, EORTC has been performing the Oncology Case Study within the EU-funded project HTx (Next Generation Health Technology Assessment to support patient-centred, societally oriented, real-time decision-making on access and reimbursement for health technologies throughout Europe)  to deliver solutions to select patients with head and neck cancer who are most likely to benefit from proton therapy.

Proton therapy has been particularly applied to patients with head and neck cancer to reduce risks of treatment-related side effects such as dysphagia and xerostomia. As proton therapy is a resource-demanding treatment modality with limited capacity, it is crucial to identify patients who will benefit the most from proton therapy. We developed models that predict the likelihood for a particular patient to develop side effects (e.g. xerostomia/dysphagia) under photon or proton therapy. If prediction shows that proton therapy reduces the risk of side effects beyond a predefined clinically relevant threshold, the patient is selected to receive proton therapy. Meanwhile, we project this patient selection approach to a population level to see how much gain/loss the society would expect.

HTx has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 825162. The workshop is supported by an award from PTCOG. Dr Lifang Liu, EORTC scientific representative in the HTx project received the award during the PTCOG 61 Conference in Madrid, 10-16 June 2023.

Access the meeting agenda here.

Next events

  • HTx proton therapy case study workshop

    Brussels, Belgium (hybrid)

  • EORTC Melanoma Group Autumn Meeting 2024

    Barcelona, Spain

  • CDDF-EORTC Workshop on Innovation and Access in Rare Cancers

    Amsterdam, NL (Hybrid Event)

  • EORTC Quality of Life Group Autumn Meeting 2024

    Innsbruck, Austria

  • EORTC Pathobiology Group Autumn Meeting 2024

    Virtual Event